Recombinant Human VEGFC (Myc Tag, His Tag)
ED50
/
Species
Human
Purity
>90 %, SDS-PAGE
GeneID
7424
Accession
P49767
验证数据展示
Technical Specifications
Purity | >90 %, SDS-PAGE |
Endotoxin Level | <1.0 EU/μg protein, LAL method |
Biological Activity |
/ |
Source | HEK293-derived Human VEGFC protein Thr103-Arg227 (Accession# P49767) with a Myc Tag and a His Tag at the C-terminus. |
Predicted Molecular Mass | 16.1 kDa |
SDS-PAGE | 20-30 kDa, reducing (R) conditions |
Formulation | Lyophilized from sterile PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
Reconstitution | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
Storage |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
Background
Vascular endothelial growth factor C (VEGF-C) is a protein that is a member of the platelet-derived growth factor / vascular endothelial growth factor (PDGF/VEGF) family. The main function of VEGF-C is to promote the growth of lymphatic vessels (lymphangiogenesis). It acts on lymphatic endothelial cells (LECs) primarily via its receptor VEGFR-3 promoting survival, growth and migration. Apart from vascular targets, VEGF-C is also important for neural development and blood pressure regulation.
References:
1. V Joukov. et al. (1996) EMBO J. 1996 Jan 15;15(2):290-98. 2. Barbara Le Bras. et al. (2006) Nat Neurosci. Mar;9(3):340-8. 3. Agnes Machnik. et al. (2009) Nat Med. 15(5):545-52.